Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuki Fukami

Showing results (111-120 of 177) with videos related to

Pageof 18
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2016
Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In VivoMitsutoshi Asakura, Tatsuki Fukami, Miki Nakajima, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 22, 2004
Metabolic profile of nicotine in subjects whose CYP2A6 gene is deletedHiroyuki Yamanaka, Miki Nakajima, Kiyoko Nishimura, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 15, 2015
Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in RatsAzumi Iida, Eita Sasaki, Azusa Yano, et al.
Toxicology|May 28, 2014
Changes in the expression of miRNAs at the pericentral and periportal regions of the rat liver in response to hepatocellular injury: comparison with the changes in the expression of plasma miRNAsYu Yamaura, Miki Nakajima, Naoyuki Tatsumi, et al.
Toxicology Letters|December 3, 2014
Role of cytochrome P450-mediated metabolism and identification of novel thiol-conjugated metabolites in mice with phenytoin-induced liver injuryEita Sasaki, Atsushi Iwamura, Koichi Tsuneyama, et al.
Drug Metabolism and Pharmacokinetics|October 10, 2020
Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase/reductase isoforms in human liversKeito Amai, Tatsuki Fukami, Hiroyuki Ichida, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 15, 2010
Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophenAkinobu Watanabe, Tatsuki Fukami, Shiori Takahashi, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 5, 2009
An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and gamma-glutamylcysteine synthetase knockdown cellsHiroko Hosomi, Sho Akai, Keiichi Minami, et al.
Pharmacogenetics and Genomics|August 14, 2008
Genetic polymorphisms of CYP2A6 affect the in-vivo pharmacokinetics of pilocarpineTakuro Endo, Miki Nakajima, Tatsuki Fukami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 3, 2015
Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukastShingo Oda, Ryoichi Fujiwara, Yuki Kutsuno, et al.
Pageof 18

Showing results (111-120 of 177) with videos related to

Sort By:
Pageof 18
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2016
Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In VivoMitsutoshi Asakura, Tatsuki Fukami, Miki Nakajima, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 22, 2004
Metabolic profile of nicotine in subjects whose CYP2A6 gene is deletedHiroyuki Yamanaka, Miki Nakajima, Kiyoko Nishimura, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 15, 2015
Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in RatsAzumi Iida, Eita Sasaki, Azusa Yano, et al.
Toxicology|May 28, 2014
Changes in the expression of miRNAs at the pericentral and periportal regions of the rat liver in response to hepatocellular injury: comparison with the changes in the expression of plasma miRNAsYu Yamaura, Miki Nakajima, Naoyuki Tatsumi, et al.
Toxicology Letters|December 3, 2014
Role of cytochrome P450-mediated metabolism and identification of novel thiol-conjugated metabolites in mice with phenytoin-induced liver injuryEita Sasaki, Atsushi Iwamura, Koichi Tsuneyama, et al.
Drug Metabolism and Pharmacokinetics|October 10, 2020
Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase/reductase isoforms in human liversKeito Amai, Tatsuki Fukami, Hiroyuki Ichida, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 15, 2010
Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophenAkinobu Watanabe, Tatsuki Fukami, Shiori Takahashi, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 5, 2009
An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and gamma-glutamylcysteine synthetase knockdown cellsHiroko Hosomi, Sho Akai, Keiichi Minami, et al.
Pharmacogenetics and Genomics|August 14, 2008
Genetic polymorphisms of CYP2A6 affect the in-vivo pharmacokinetics of pilocarpineTakuro Endo, Miki Nakajima, Tatsuki Fukami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 3, 2015
Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukastShingo Oda, Ryoichi Fujiwara, Yuki Kutsuno, et al.
Pageof 18